Laurus Labs Limited
BSE:540222 Stock Report
Laurus Labs Dividends and Buybacks
Dividend criteria checks 1/6 Laurus Labs is a dividend paying company with a current yield of 0.16% that is well covered by earnings. Next payment date is on 23rd November, 2024 with an ex-dividend date of 6th November, 2024.
Key information Total Shareholder Yield 0.1% Future Dividend Yield 0.4% Dividend Growth -2.4% Next dividend pay date 23 Nov 24 Ex dividend date 06 Nov 24 Dividend per share ₹0.800 Payout ratio 33%
Recent dividend and buyback updates
Laurus Labs Limited Approves Interim Dividend for the Financial Year 2024- 2025 Oct 24
Upcoming dividend of ₹0.40 per share at 0.4% yield Oct 26 Laurus Labs Limited Approves Interim Dividend, Payable on or After November 09, 2023
Upcoming dividend of ₹1.20 per share at 0.6% yield May 03
Upcoming dividend of ₹0.80 per share Oct 27
Laurus Labs Limited Approves Interim Dividend for the Financial Year 2022-2023, Payable on or After November 15, 2022 Oct 22
Show all updates
First half dividend of ₹0.40 announced Oct 26
Second quarter 2025 earnings: EPS and revenues miss analyst expectations Oct 25
Laurus Labs Limited Approves Interim Dividend for the Financial Year 2024- 2025 Oct 24
Laurus Labs Limited to Report Q2, 2025 Results on Oct 24, 2024 Oct 17
Laurus Labs Limited Appoints Ramesh Subrahmanian as A Non-Executive Independent Director Oct 03
First quarter 2025 earnings: EPS and revenues miss analyst expectations Jul 26
Laurus Labs Limited to Report Q1, 2025 Results on Jul 25, 2024 Jul 22
Laurus Labs Limited Announces Board Appointments Jul 12
Full year 2024 earnings: EPS misses analyst expectations Jun 20
Less than half of directors are independent May 21
Final dividend reduced to ₹0.40 Apr 27
Laurus Labs Limited, Annual General Meeting, Jul 11, 2024 Apr 27
Full year 2024 earnings: EPS misses analyst expectations Apr 26 Laurus Labs Limited Approves Board Changes
Laurus Labs Limited to Report Q4, 2024 Results on Apr 25, 2024 Apr 19
Third quarter 2024 earnings: EPS and revenues miss analyst expectations Jan 25
Laurus Labs Limited to Report Q3, 2024 Results on Jan 24, 2024 Jan 17
Upcoming dividend of ₹0.40 per share at 0.4% yield Oct 26
Price target increased by 7.2% to ₹371 Oct 24
Second quarter 2024 earnings: EPS and revenues miss analyst expectations Oct 21 Laurus Labs Limited Approves Interim Dividend, Payable on or After November 09, 2023
Laurus Labs Limited to Report Q2, 2024 Results on Oct 20, 2023 Oct 14
Laurus Labs Limited (NSEI:LAURUSLABS) agreed to acquire an additional 14.54% stake in Laurus Bio Private Limited from one of the Promoters, non-executive director, his family members and few Employee/ex-Employee shareholders for approximately INR 720 million. Sep 12
Investor sentiment improves as stock rises 16% Aug 04
New minor risk - Profit margin trend Jul 28
First quarter 2024 earnings released: EPS: ₹0.46 (vs ₹4.68 in 1Q 2023) Jul 28
Full year 2023 earnings: EPS and revenues miss analyst expectations Jun 24
Laurus Labs Limited (NSEI:LAURUSLABS) signed an investment agreement to acquire additional 7.24% stake in Immunoadoptive Cell Therapy Private Limited for INR 800 million. Jun 01
Upcoming dividend of ₹1.20 per share at 0.6% yield May 03
Price target decreased by 11% to ₹382 Apr 30
Full year 2023 earnings: EPS and revenues miss analyst expectations Apr 28
Price target decreased by 10% to ₹470 Feb 01
Third quarter 2023 earnings: EPS and revenues exceed analyst expectations Jan 31
Laurus Labs Limited to Report Q3, 2023 Results on Jan 30, 2023 Jan 22 Laurus Labs Limited announced that it expects to receive INR 38.998 million in funding from Ethan Energy India Private Limited Nov 25
Price target decreased to ₹561 Nov 16
Insufficient new directors Nov 16
Consensus EPS estimates fall by 14% Oct 28
Upcoming dividend of ₹0.80 per share Oct 27
Price target decreased to ₹574 Oct 26
Laurus Labs Limited Approves Interim Dividend for the Financial Year 2022-2023, Payable on or After November 15, 2022 Oct 22
Second quarter 2023 earnings: EPS and revenues miss analyst expectations Oct 22
Laurus Labs Limited to Report Q2, 2023 Results on Oct 21, 2022 Oct 14
First quarter 2023 earnings: EPS and revenues exceed analyst expectations Jul 28
Laurus Labs Limited to Report Q1, 2023 Results on Jul 27, 2022 Jul 20
Investor sentiment deteriorated over the past week Jun 20
Full year 2022 earnings: Revenues and EPS in line with analyst expectations Jun 09
Upcoming dividend of ₹1.20 per share May 03
Full year 2022 earnings: Revenues and EPS in line with analyst expectations Apr 29
Insufficient new directors Apr 27
Laurus Labs Limited to Report Q4, 2022 Results on Apr 28, 2022 Apr 22
Consensus revenue estimates fall by 14% Feb 03
Price target decreased to ₹563 Feb 02
Third quarter 2022 earnings: EPS and revenues miss analyst expectations Jan 28
Upcoming dividend of ₹0.80 per share Nov 10
Second quarter 2022 earnings released: EPS ₹3.76 (vs ₹4.53 in 2Q 2021) Nov 01
Investor sentiment deteriorated over the past week Oct 22
Insider recently sold ₹7.9m worth of stock Sep 22
Insider recently sold ₹3.2m worth of stock Sep 11
Insider recently sold ₹3.6m worth of stock Sep 04
Insider recently sold ₹1.0m worth of stock Aug 13
Price target increased to ₹561 Aug 04
First quarter 2022 earnings released: EPS ₹4.50 (vs ₹3.21 in 1Q 2021) Jul 30
Price target increased to ₹506 Jul 12
Laurus Labs Limited Receives the License to Manufacture and Market 2-Deoxy-D-Glucose (2DG) in India Jul 03
Full year 2021 earnings released: EPS ₹18.36 (vs ₹4.79 in FY 2020) Jun 24
Insider recently bought ₹4.0m worth of stock May 23
Insider recently sold ₹35m worth of stock May 07
Consensus EPS estimates increase to ₹21.57 May 06
Price target increased to ₹430 May 05
Upcoming dividend of ₹0.80 per share May 04
Full year 2021 earnings released: EPS ₹18.36 (vs ₹4.79 in FY 2020) May 01
Laurus Labs Limited Approves Third Interim Dividend, Payable on or After May 19, 2021 Apr 30
Investor sentiment improved over the past week Apr 07
Insider recently sold ₹1.5m worth of stock Mar 10
Price target raised to ₹399 Feb 23
Insider recently sold ₹1.9m worth of stock Feb 21
Insider recently bought ₹3.0m worth of stock Feb 06
Revenue and earnings beat expectations Jan 30
Third quarter 2021 earnings released: EPS ₹5.09 (vs ₹1.38 in 3Q 2020) Jan 30
Laurus Labs Limited (BSE:540222) completed the acquisition of 72.55% stake in Richcore Lifesciences Pvt. Ltd. from VenturEast Proactive Fund and VenturEast Life Fund III, L.P. managed by Ventureast Fund Advisors India Limited and Eight Roads Ventures India. Jan 22
Laurus Labs Limited to Report Q3, 2021 Results on Jan 28, 2021 Jan 20
New 90-day high: ₹372 Jan 20
Insider recently sold ₹1.5m worth of stock Jan 07
New 90-day high: ₹359 Jan 04
Insider recently sold ₹1.2m worth of stock Dec 23
New 90-day high: ₹339 Dec 16
Insider recently sold ₹1.6m worth of stock Dec 08
Laurus Labs Limited (BSE:540222) signed a definitive agreement to acquire 72.6% stake in Richcore Lifesciences Pvt. Ltd. from VenturEast Proactive Fund and VenturEast Life Fund III, L.P. managed by Ventureast Fund Advisors India Limited and Eight Roads Ventures India for INR 2.5 billion. Nov 26
Insider recently bought ₹3.4m worth of stock Nov 12
Analysts increase revenue estimates to ₹44.5b Nov 05
Upcoming Dividend of ₹0.80 Per Share Nov 03
First half earnings released Oct 30
Second-quarter earnings released: Revenue beats expectations, earnings disappoint Oct 30
Laurus Labs Limited to Report Q2, 2021 Results on Oct 29, 2020 Oct 20
Stability and Growth of Payments
Stable Dividend: 540222 has been paying a dividend for less than 10 years and during this time payments have been volatile .
Growing Dividend: 540222's dividend payments have increased, but the company has only paid a dividend for 7 years.
Dividend Yield vs Market Laurus Labs Dividend Yield vs Market
How does 540222 dividend yield compare to the market? Segment Dividend Yield Company (540222) 0.2% Market Bottom 25% (IN) 0.2% Market Top 25% (IN) 1.1% Industry Average (Pharmaceuticals) 0.7% Analyst forecast (540222) (up to 3 years) 0.4%
Notable Dividend: 540222's dividend (0.16%) isn’t notable compared to the bottom 25% of dividend payers in the Indian market (0.24%).
High Dividend: 540222's dividend (0.16%) is low compared to the top 25% of dividend payers in the Indian market (1.1%).
Earnings Payout to Shareholders
Earnings Coverage: With its reasonably low payout ratio (32.9%), 540222's dividend payments are well covered by earnings.
Cash Payout to Shareholders
Cash Flow Coverage: 540222 is paying a dividend but the company has no free cash flows.
Discover strong dividend paying companies Simply Wall St™ Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.
{"enabled":true,"variant":{"name":"display-ssr-flag","enabled":true,"feature_enabled":true,"featureEnabled":true},"flagsReady":true,"flagsError":null}